IGF1 and Alzheimer disease: According to the results of AUC analysis, low expression of IGF1 had a good diagnostic performance in AD prediction in test set (GSE132903: AUC =69.4%) and training sets (GSE5281: AUC =90.9%; GSE37264: AUC =84.4%) (Figure 4(d)).